Fred P. Lampropoulos - 27 May 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
President and CEO, Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
27 May 2025
Transactions value $
-$1,930,800
Form type
4
Filing time
29 May 2025, 13:46:13 UTC
Previous filing
06 Mar 2025
Next filing
03 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LAMPROPOULOS FRED P President and CEO, Director 1600 WEST MERIT PARKWAY, SOUTH JORDAN /s/ Brian G. Lloyd, Attorney-in-Fact 29 May 2025 0000901534

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Sale -$1.93M -20K -1.84% $96.54 1.07M 27 May 2025 Direct F1
holding MMSI Common Stock, No Par Value 7.73K 27 May 2025 By spouse
holding MMSI Common Stock, No Par Value 97.8K 27 May 2025 By 401(k) Plan
holding MMSI Common Stock, No Par Value 90 27 May 2025 By spouse as custodian for child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMSI Non-qualified stock options (right to buy) 159K 27 May 2025 Common Stock 159K $55.73 Direct F2
holding MMSI Non-qualified stock options (right to buy) 2K 27 May 2025 Common Stock 2K $55.73 By spouse F3, F4
holding MMSI Non-qualified stock options (right to buy) 100K 27 May 2025 Common Stock 100K $37.71 Direct F5
holding MMSI Non-qualified stock options (right to buy) 58.1K 27 May 2025 Common Stock 58.1K $56.25 Direct F6
holding MMSI Non-qualified stock options (right to buy) 54.3K 27 May 2025 Common Stock 54.3K $70.58 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.32 to $96.99, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
F3 Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
F4 Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
F5 Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
F6 Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
F7 Becomes exercisable in equal annual installments of 25% commencing 02/28/2024.